Skip to content
MS
Sign in
Single-pathway Pathway metabolite unreviewed

3-Ketosphinganine

0
Pathways
0
Categories
0
As substrate
0
As product
What can this become? Show on map

Reactions involving 3-Ketosphinganine

Every recorded step where this molecule takes part

All 2 Consumed 1 Produced 1

Showing all 2 reactions.

Recent literature

Refresh

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Targeting lipid metabolic vulnerabilities with small-molecule inhibitors in acute myeloid leukemia: Emerging insights and therapeutic opportunities.

    Yen JH, Phan TQ, Liou JW, Chen PY. · 2026-07-25

    open access unreviewed
  2. 2
    The role of sphingolipids in major depressive disorder and associated cognitive impairment: interactions with monoaminergic signaling, neuroinflammation, and neurogenesis.

    Hoertel N, Mühle C, Müller CP, Chaieb H, Scheer V, Fayad M, Sánchez-Rico M, Limosin F, Kornhuber J. · 2026-05-13

    cited 1× open access unreviewed
  3. 3
    ROS/pH-Responsive Phenylboronic Acid-Chitosan Nanoparticles Improve Silymarin-Mediated Hepatoprotection After Hepatectomy With Gut-Liver Axis-Associated Responses.

    Tong J, Luo C, Liu Z, Zhang X, Jia D, Sun Y, Zhang Z, Shi H, Wang J, Zhang H. · 2026-09-27

    open access unreviewed
  4. 4
    Cucumber Mosaic Virus Promotes Sphingolipid Biosynthesis to Alleviate Host Unfolded Protein Response (UPR)-Mediated Immunity.

    Yao J, Wu S, Gao S, Xiang Z, Wang Q, Ye F, Liao Q, Gu Z, Du Z. · 2026-09-01

    open access unreviewed
  5. 5
    Mapping the causal chain from genetic risk variants to lipid dysmetabolism in Parkinson's disease.

    De-Paula RB, Kim J, Rhinn H, Saade H, Chavez F, Segura T, Lozano MV, Etoundi M, Silos K, Kass N, Korchina V, … · 2026-09-01

    cited 4× open access unreviewed
  6. 6
    Reprogramming lipid metabolism in virus-infected neuronal cells

    · 2026-08-10

    open access unreviewed
  7. 7
    Ceramides: A Biologically Attractive Lipid and Advances in Acquisition Strategies.

    Yan Y, Ren X, Wu Y, Li L, Yuan H. · 2026-08-22

    open access unreviewed
  8. 8
    Sphingolipid Metabolism Links Morphological Signatures to Immunomodulatory Potency in Human Mesenchymal Stromal Cells.

    Shah DC, Leitmann BW, Priyadarshani P, DeVeaux SA, Munoz C, Zhang Y, Rui K, Chiappa NF, Hymel LA, York W, Ogl… · 2026-08-27

    open access unreviewed
  9. 9
    Disruption of sphingolipid metabolism promotes tau seeding through endolysosomal membrane rigidification and rupture.

    Tittelmeier J, Sandhof CA, Martin N, El-Kabarity D, Ngonza-Nito SB, Melki R, Nussbaum-Krammer C. · 2026-08-27

    cited 3× open access unreviewed
  10. 10
    Sphingolipids and Atherosclerosis.

    Li X, Li Z, Jiang XC. · 2026-08-06

    unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.